BioCentury | Mar 3, 2008
Finance

Ebb & Flow

...James Dougherty and Steven Soignet - both of whom had been venture partners at Cross Atlantic Partners...
BioCentury | Oct 10, 2005
Finance

Ebb & Flow

...MPM/BB Bioventure (12.1% prior to the IPO); ELN (7.4%); Forward Ventures (6.5%); Easton Hunt (6.4%); Cross Atlantic Partners...
BioCentury | Apr 5, 2004
Company News

Eximias board of directors update

...Eximias Pharmaceutical Corp. , Berwyn, Penn. Business: Cancer Appointed: John Cassis, partner at Cross Atlantic Partners; Brenda Gavin...
BioCentury | Apr 5, 2004
Finance

Ebb & Flow

...companies doing especially well. Eximias raised $63.5 million in a series D round co-led by Cross Atlantic Partners...
BioCentury | Mar 31, 2004
Financial News

Eximias raises $63.5 million

...Cancer company Eximias (Berwyn, Penn.) raised $63.5 million in a series D round co-led by Cross Atlantic Partners...
...Technology Partners. Ferghana Securities served as placement agent and advisor. John Cassis, a partner at Cross Atlantic Partners...
BioCentury | Oct 6, 2003
Finance

Ebb & Flow

...7.9%); Forward Ventures (7.1%); Easton Hunt (5.8%); MDS (5.5%); and TVM; ABN Amro; JPMorgan; and Cross Atlantic Partners...
BioCentury | May 12, 2003
Finance

Ebb & Flow

...estimated the cash will last for at least three years. Other investors included ABN AMRO; Cross Atlantic Partners...
BioCentury | May 9, 2003
Top Story

Acorda raises $55.3M

...in a private round led by Easton Hunt Capital Partners. Other investors included ABN AMRO; Cross Atlantic Partners...
BioCentury | Aug 13, 2001
Finance

Ebb & Flow

...RZYM, which is developing ribozyme-based drugs for infectious diseases, is a Morgenthaler portfolio company. Meanwhile, Cross Atlantic Partners...
BioCentury | Jan 10, 2000
Finance

Bigger launching pad

...managing director at the private merchant bank. Dimmler had been an investment officer of the Cross Atlantic Partners...
Items per page:
1 - 10 of 10
BioCentury | Mar 3, 2008
Finance

Ebb & Flow

...James Dougherty and Steven Soignet - both of whom had been venture partners at Cross Atlantic Partners...
BioCentury | Oct 10, 2005
Finance

Ebb & Flow

...MPM/BB Bioventure (12.1% prior to the IPO); ELN (7.4%); Forward Ventures (6.5%); Easton Hunt (6.4%); Cross Atlantic Partners...
BioCentury | Apr 5, 2004
Company News

Eximias board of directors update

...Eximias Pharmaceutical Corp. , Berwyn, Penn. Business: Cancer Appointed: John Cassis, partner at Cross Atlantic Partners; Brenda Gavin...
BioCentury | Apr 5, 2004
Finance

Ebb & Flow

...companies doing especially well. Eximias raised $63.5 million in a series D round co-led by Cross Atlantic Partners...
BioCentury | Mar 31, 2004
Financial News

Eximias raises $63.5 million

...Cancer company Eximias (Berwyn, Penn.) raised $63.5 million in a series D round co-led by Cross Atlantic Partners...
...Technology Partners. Ferghana Securities served as placement agent and advisor. John Cassis, a partner at Cross Atlantic Partners...
BioCentury | Oct 6, 2003
Finance

Ebb & Flow

...7.9%); Forward Ventures (7.1%); Easton Hunt (5.8%); MDS (5.5%); and TVM; ABN Amro; JPMorgan; and Cross Atlantic Partners...
BioCentury | May 12, 2003
Finance

Ebb & Flow

...estimated the cash will last for at least three years. Other investors included ABN AMRO; Cross Atlantic Partners...
BioCentury | May 9, 2003
Top Story

Acorda raises $55.3M

...in a private round led by Easton Hunt Capital Partners. Other investors included ABN AMRO; Cross Atlantic Partners...
BioCentury | Aug 13, 2001
Finance

Ebb & Flow

...RZYM, which is developing ribozyme-based drugs for infectious diseases, is a Morgenthaler portfolio company. Meanwhile, Cross Atlantic Partners...
BioCentury | Jan 10, 2000
Finance

Bigger launching pad

...managing director at the private merchant bank. Dimmler had been an investment officer of the Cross Atlantic Partners...
Items per page:
1 - 10 of 10